JB Chemicals board meeting scheduled for May 11, 2026, to approve audited financial results for Q4 and FY26.
Agenda includes consideration of standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Board will also recommend a final dividend for FY 2025-26, subject to subsequent shareholder approval.
Disclosure made under SEBI Listing Regulations as a mandatory intimation of upcoming board meeting agenda.